Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT05172518 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05172518
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Locally Advanced or Metastatic Breast Cancer

Start date: 2022-03-01
Primary completion: 2027-03-01
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.